MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$21,356
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
0
0
0*
0
General and administrative
17,554
60,271
-85,691
115,099
Total operating expenses
17,554
60,271
-85,691*
115,099
Gain from operations
-17,554
-60,271
85,691*
-115,099
Liability forgiveness
-
-
15,386.5*
-
Liability extinguishment
-
20,000
-
-
Liability forgiveness
0
-
-
-
Interest expense - related parties
3,802
3,503
2,167*
2,710
Total other expenses
-
-
-
2,710
Total other income (expense)
-3,802
16,497
13,219.5*
-
Gain before income tax expense
-
-
98,910.5*
-117,809
Income tax expense
-
-
0*
0
Net gain
-21,356
-43,774
98,910.5
-117,809
Diluted EPS
0
0
0.002
0
Diluted Average Shares
60,042,000
60,042,000
60,042,000
60,042,000
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net gain
-$21,356
(-37.23%↓ Y/Y)
Gain from operations
-$17,554
(-28.94%↓ Y/Y)
Total other income
(expense)
-$3,802
Total operating
expenses
$17,554
(28.94%↑ Y/Y)
Interest expense -
related parties
$3,802
(95.17%↑ Y/Y)
General and
administrative
$17,554
(28.94%↑ Y/Y)
Buy us a coffee
ACRO BIOMEDICAL CO., LTD. (ACBM)
ACRO BIOMEDICAL CO., LTD. (ACBM)